Citation Impact
Citing Papers
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
2012 StandoutScience
Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus
2009 StandoutNobel
Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program
2007 StandoutNobel
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
2007 StandoutNobel
TLR7-dependent and FcγR-independent production of type I interferon in experimental mouse lupus
2008
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
Plasmacytoid Dendritic Cells Regulate Autoreactive B Cell Activation via Soluble Factors and in a Cell-to-Cell Contact Manner
2009
Expression Profile of FcγRIIb on Leukocytes and Its Dysregulation in Systemic Lupus Erythematosus
2007
Group A Streptococcus Activates Type I Interferon Production and MyD88-dependent Signaling without Involvement of TLR2, TLR4, and TLR9
2008 StandoutNobel
Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases
2003
UV Light Potentiates STING (Stimulator of Interferon Genes)-dependent Innate Immune Signaling through Deregulation of ULK1 (Unc51-like Kinase 1)
2015 StandoutNobel
IRF-7 is the master regulator of type-I interferon-dependent immune responses
2005 StandoutNature
Plasmacytoid Dendritic Cells (Natural Interferon- α/β-Producing Cells) Accumulate in Cutaneous Lupus Erythematosus Lesions
2001
Atopic Dermatitis
2008 Standout
Efficient T Cell Activation via a Toll-Interleukin 1 Receptor-Independent Pathway
2006 StandoutNobel
Psoriasis
2009 Standout
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
2009 StandoutNature
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Regulation of the type I IFN induction: a current view
2005
Type I interferons in Sjögren's syndrome
2012
Development of TLR inhibitors for the treatment of autoimmune diseases
2008
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
2005
Pathogenesis and therapy of psoriasis
2007 StandoutNature
An etiopathogenic role for the type I IFN system in SLE
2001
Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system
2006
A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNA
2005
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance
2010
B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximab
2004
Type I Interferon in Systemic Lupus Erythematosus
2007
Dendritic cells: versatile controllers of the immune system
2007 StandoutNobel
Pattern Recognition Receptors and Inflammation
2010 Standout
Antiinfective Applications of Toll-like Receptor 9 Agonists
2007
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Toll-like receptors in systemic autoimmune disease
2006
Polymorphisms in the Tyrosine Kinase 2 and Interferon Regulatory Factor 5 Genes Are Associated with Systemic Lupus Erythematosus
2005
Induction of interferon‐α production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG
2004
Intracellular Toll-like Receptors
2010 StandoutNobel
Innate immune recognition of, and regulation by, DNA
2006
Toll-Like Receptors and Activation of Autoreactive B Cells
2002
Type I Interferon in Systemic Lupus Erythematosus and Other Autoimmune Diseases
2006
Systemic Lupus Erythematosus
2011 Standout
Endogenous TLR Ligands and Autoimmunity
2006
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Rheumatoid Arthritis Synovium Contains Two Subsets of CD83−DC-LAMP− Dendritic Cells with Distinct Cytokine Profiles
2008
Systemic lupus erythematosus: all roads lead to type I interferons
2006
The type I interferon system in the etiopathogenesis of autoimmune diseases
2011
Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA
2005 StandoutNobel
Nucleic acid‐mediated inflammatory diseases
2008
Recognition of Hyaluronan Released in Sterile Injury Involves a Unique Receptor Complex Dependent on Toll-like Receptor 4, CD44, and MD-2
2007 StandoutNobel
Oxidative Damage of DNA Confers Resistance to Cytosolic Nuclease TREX1 Degradation and Potentiates STING-Dependent Immune Sensing
2013
Toll‐like receptors, endogenous ligands, and systemic autoimmune disease
2005
Plasmacytoid dendritic cells in immunity
2004
Interferon-producing cells: on the front line in immune responses against pathogens
2002
The type I interferon system in systemic lupus erythematosus
2006
Intracellular mammalian DNA stimulates myeloid dendritic cells to produce type I interferons predominantly through a toll‐like receptor 9–independent pathway
2006
Plasmacytoid Dendritic Cells: A New Cutaneous Dendritic Cell Subset with Distinct Role in Inflammatory Skin Diseases
2002
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
2008 StandoutNature
Monoclonal antibodies for cancer immunotherapy
2009
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Pathogen Recognition and Innate Immunity
2006 Standout
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
2005 Standout
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Trex1 Exonuclease Degrades ssDNA to Prevent Chronic Checkpoint Activation and Autoimmune Disease
2007 StandoutNobel
Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells
2010 StandoutNobel
Development of Monocytes, Macrophages, and Dendritic Cells
2010 StandoutScience
Ultraviolet light and cutaneous lupus
2006
The CD8+ Dendritic Cell Subset Selectively Endocytoses Dying Cells in Culture and In Vivo
2002 StandoutNobel
Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients
2006 StandoutNobel
Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing
2009 StandoutNobel
Expression of an anti‐RNA autoantibody in a mouse model of SLE increases neutrophil and monocyte numbers as well as IFN ‐I expression
2013
A cell-surface molecule selectively expressed on murine natural interferon–producing cells that blocks secretion of interferon-alpha
2003
Immunologically Active Autoantigens: The Role of Toll-Like Receptors in the Development of Chronic Inflammatory Disease
2007
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
2005
Programmed assembly of 3-dimensional microtissues with defined cellular connectivity
2009 StandoutNobel
U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7
2005
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
CpG Motifs in Bacterial DNA and Their Immune Effects
2002 Standout
Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response
2012 StandoutNobel
The Role of Complement in the Development of Systemic Lupus Erythematosus
2004
IFN-α Induces Early Lethal Lupus in Preautoimmune (New Zealand Black × New Zealand White)F1 but Not in BALB/c Mice
2005
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Foxp3+natural regulatory T cells preferentially form aggregates on dendritic cellsin vitroand actively inhibit their maturation
2008 StandoutNobel
Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)
2005 StandoutNobel
Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger
2008 StandoutNobel
IPC: Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell Precursors
2004
Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8
2005
HMGB1 and RAGE in Inflammation and Cancer
2010
Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance
2002 StandoutNobel
Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus
2006 StandoutNobel
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
2003 Standout
Endosomal Translocation of Vertebrate DNA Activates Dendritic Cells via TLR9-Dependent and -Independent Pathways
2005
Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus
2005
Regulation of Adaptive Immunity by the Innate Immune System
2010 StandoutScience
A Pivotal Role for the Natural Interferon α–producing Cells (Plasmacytoid Dendritic Cells) in the Pathogenesis of Lupus
2001
Tolerogenic Dendritic Cells
2003 StandoutNobel
Toll-like Receptor 9–Dependent and –Independent Dendritic Cell Activation by Chromatin–Immunoglobulin G Complexes
2004
RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates
2006 StandoutScience
Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
2006 StandoutScienceNobel
Role of Natural Interferon-α Producing Cells (Plasmacytoid Dendritic Cells) in Autoimmunity
2003
BDCA-2, a Novel Plasmacytoid Dendritic Cell–specific Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon α/β Induction
2001
Works of Anders Perers being referenced
Patients with Systemic Lupus Erythematosus have Reduced Numbers of Circulating Natural Interferon-α- Producing Cells
1998
Anti-Double-Stranded DNA Antibodies and Immunostimulatory Plasmid DNA in Combination Mimic the Endogenous IFN-α Inducer in Systemic Lupus Erythematosus
1999
FcγRIIa Is Expressed on Natural IFN-α-Producing Cells (Plasmacytoid Dendritic Cells) and Is Required for the IFN-α Production Induced by Apoptotic Cells Combined with Lupus IgG
2003
Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus.
1999